Table 2.
Characteristics of the study population by KIF14 immunoexpression groups.
Variables | n (%) | KIF14 IS | p -Value | KIF14 PS | p-Value | KIF14 IRS | p-Value | |||
---|---|---|---|---|---|---|---|---|---|---|
↓ n = 21 (30.88) | ↑ n = 47 (69.12) | ↓ n = 31 (45.59) |
↑ n = 37 (54.41) | ↓ n = 30 (44.12) | ↑ n = 38 (55.88) | |||||
Age (years) | ||||||||||
≤ 60 | 29 (42.65) | 8 (27.59) | 21 (72.41) | 0.79 | 14 (48.28) | 15 (51.72) | 0.81 | 14 (48.28) | 15 (51.72) | 0.63 |
> 60 | 39 (57.35) | 13 (33.33) | 26 (66.67) | 17 (43.59) | 22 (56.41) | 16 (41.03) | 23 (58.97) | |||
Gender | ||||||||||
Male | 34 (50.00) | 8 (23.53) | 26 (76.47) | 0.29 | 15 (44.12) | 19 (55.88) | >0.99 | 13 (38.24) | 21 (61.76) | 0.46 |
Female | 34 (50.00) | 13 (38.24) | 21 (61.76) | 16 (47.06) | 18 (52.94) | 17 (50.00) | 17 (50.00) | |||
Grading | ||||||||||
G1 | 5 (7.35) | 1 (20.00) | 4 (80.00) | 0.10 | 3 (60.00) | 2 (40.00) | 0.40 | 2 (40.00) | 3 (60.00) | 0.15 |
G2 | 55 (80.88) | 20 (36.36) | 35 (63.64) | 26 (47.27) | 29 (52.73) | 27 (49.09) | 28 (50.91) | |||
G3 | 8 (11.77) | 0 (0.00) | 8 (100.0) | 2 (25.00) | 6 (75.00) | 1 (12.50) | 7 (87.50) | |||
pT status | ||||||||||
T1 | 10 (15.87) | 4 (40.00) | 6 (60.00) | 0.56 | 6 (60.00) | 4 (40.00) | 0.40 | 5 (50.00) | 5 (50.00) | 0.83 |
T2 | 43 (68.25) | 11 (25.58) | 32 (74.42) | 19 (44.19) | 24 (55.81) | 17 (39.54) | 26 (60.47) | |||
T3-T4 | 10 (15.87) | 2 (20.00) | 8 (80.00) | 3 (30.00) | 7 (70.00) | 4 (40.00) | 6 (60.00) | |||
pN status | ||||||||||
N0 | 30 (45.46) | 8 (26.67) | 22 (73.33) | 0.44 | 18 (60.00) | 12 (40.00) | 0.08 | 13 (43.33) | 17 (56.67) | 0.81 |
N1-N2 | 36 (54.54) | 13 (36.11) | 23 (63.89) | 13 (36.11) | 23 (63.89) | 17 (47.22) | 19 (52.78) | |||
TNM stage | ||||||||||
I | 24 (38.71) | 6 (25.00) | 18 (75.00) | 0.43 | 15 (62.50) | 9 (37.50) | 0.12 | 10 (41.67) | 14 (58.33) | 0.86 |
II | 24 (38.71) | 6 (25.00) | 18 (75.00) | 8 (33.33) | 16 (66.67) | 10 (41.67) | 14 (58.33) | |||
III-IV | 14 (22.58) | 6 (42.86) | 8 (57.14) | 6 (42.86) | 8 (57.14) | 7 (50.00) | 7 (50.00) | |||
Location | ||||||||||
Head | 60 (88.24) | 19 (31.67) | 41 (68.33) | >0.99 | 28 (46.67) | 32 (53.33) | 0.72 | 26 (43.33) | 34 (56.67) | 0.72 |
Body-tail | 8 (11.76) | 2 (25.00) | 6 (75.00) | 3 (37.50) | 5 (62.50) | 4 (50.00) | 4 (50.00) | |||
VI | ||||||||||
Absent | 39 (72.22) | 14 (35.90) | 25 (64.10) | 0.18 | 20 (51.28) | 19 (48.72) | >0.99 | 19 (48.72) | 20 (51.28) | 0.37 |
Present | 15 (27.78) | 2 (13.33) | 13 (86.67) | 7 (46.67) | 8 (53.33) | 5 (33.33) | 10 (66.67) | |||
PNI Absent Present |
22 (34.38) |
5 (22.73) |
17 (77.27) |
0.57 |
10 (45.45) |
12 (54.55) |
>0.99 |
9 (40.91) | 13 (59.09) |
>0.99 |
42 (65.62) | 14 (33.33) | 28 (66.67) | 19 (45.24) | 23 (54.76) | 18 (42.86) | 24 (57.14) |
Abbreviations: IS—immunointensity; PS—immunopercentage; IRS—immunoreactive score; VI—vascular invasion; PNI—perineural invasion. Chi-square or Fisher’s exact test.